
Experts urge FDA to remove black box warning on low-dose vaginal estrogen
On Thursday, July 17, 2025, the FDA convened a panel of experts to discuss the use of hormone replacement therapy (HRT) in menopausal women.1 These experts urged the agency to revise or remove the current black box warning label on vaginal estrogen …